{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["keratinocyte", "lipid metabolism", "narciclasine", "phospholipase A2", "psoriasis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36700214", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "01", "Day": "04"}], "Language": ["eng"], "ELocationID": ["1094375", "10.3389/fimmu.2022.1094375"], "Journal": {"ISSN": "1664-3224", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in immunology", "ISOAbbreviation": "Front Immunol"}, "ArticleTitle": "Narciclasine inhibits phospholipase A2 and regulates phospholipid metabolism to ameliorate psoriasis-like dermatitis.", "Pagination": {"StartPage": "1094375", "MedlinePgn": "1094375"}, "Abstract": {"AbstractText": ["Psoriasis is a common inflammatory skin disease recognized by the World Health Organization as \"an incurable chronic, noninfectious, painful, disfiguring and disabling disease.\" The fact that metabolic syndrome (MetS) is the most common and important comorbidities of psoriasis suggests an important role of lipid metabolism in the pathogenesis of psoriasis. Narciclasine (Ncs) is an alkaloid isolated from the Amaryllidaceae plants. Its biological activities include antitumor, antibacterial, antiinflammatory, anti-angiogenic and promoting energy expenditure to improve dietinduced obesity. Here, we report that Ncs may be a potential candidate for psoriasis, acting at both the organismal and cellular levels.", "The therapeutic effect of Ncs was assessed in IMQ-induced psoriasis-like mouse model. Then, through in vitro experiments, we explored the inhibitory effect of Ncs on HaCaT cell proliferation and Th17 cell polarization; Transcriptomics and lipidomics were used to analyze the major targets of Ncs; Single-cell sequencing data was used to identify the target cells of Ncs action.", "Ncs can inhibit keratinocyte proliferation and reduce the recruitment of immune cells in the skin by inhibiting psoriasis-associated inflammatory mediators. In addition, it showed a direct repression effect on Th17 cell polarization. Transcriptomic and lipidomic data further revealed that Ncs extensively regulated lipid metabolismrelated genes, especially the Phospholipase A2 (PLA2) family, and increased antiinflammatory lipid molecules. Combined with single-cell data analysis, we confirmed that keratinocytes are the main cells in which Ncs functions.", "Taken together, our findings indicate that Ncs alleviates psoriasiform skin inflammation in mice, which is associated with inhibition of PLA2 in keratinocytes and improved phospholipid metabolism. Ncs has the potential for further development as a novel anti-psoriasis drug."], "CopyrightInformation": "Copyright \u00a9 2023 Kong, Jiang, Huang, Liu, Jin, Li, Wei, Liu, Yin, Zhang, Tong and Chen."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}], "LastName": "Kong", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}], "LastName": "Jiang", "ForeName": "Jian", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}], "LastName": "Huang", "ForeName": "Yuqiong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}], "LastName": "Liu", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}], "LastName": "Jin", "ForeName": "Zilin", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China."}], "LastName": "Li", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Union Shenzhen Hospital, Huazhong University of Science and Technology, Shenzhen, Guangdong, China."}], "LastName": "Wei", "ForeName": "Fen", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}], "LastName": "Liu", "ForeName": "Xinxin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji-Rongcheng Center for Biomedicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}], "LastName": "Yin", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji-Rongcheng Center for Biomedicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}], "LastName": "Zhang", "ForeName": "Yonghui", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji-Rongcheng Center for Biomedicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}], "LastName": "Tong", "ForeName": "Qingyi", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China."}, {"Identifier": [], "Affiliation": "Department of Dermatology, Union Shenzhen Hospital, Huazhong University of Science and Technology, Shenzhen, Guangdong, China."}], "LastName": "Chen", "ForeName": "Hongxiang", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Immunol", "NlmUniqueID": "101560960", "ISSNLinking": "1664-3224"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "EC 3.1.1.4", "NameOfSubstance": "Group IV Phospholipases A2"}, {"RegistryNumber": "P1QW714R7M", "NameOfSubstance": "Imiquimod"}, {"RegistryNumber": "29477-83-6", "NameOfSubstance": "narciclasine"}, {"RegistryNumber": "0", "NameOfSubstance": "Phospholipids"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Dermatitis"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Group IV Phospholipases A2"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Imiquimod"}, {"QualifierName": [], "DescriptorName": "Lipid Metabolism"}, {"QualifierName": [], "DescriptorName": "Phospholipids"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Psoriasis"}], "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bandyopadhyay M, Larregina AT. Keratinocyte-polyamines and dendritic cells: a bad duet for psoriasis. Immunity (2020) 53(1):16\u20138. doi: 10.1016/j.immuni.2020.06.015", "ArticleIdList": ["10.1016/j.immuni.2020.06.015", "32668224"]}, {"Citation": "Hao Y, Zhu YJ, Zou S, Zhou P, Hu YW, Zhao QX, et al. . Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions. Front Immunol (2021) 12:711060. doi: 10.3389/fimmu.2021.711060", "ArticleIdList": ["10.3389/fimmu.2021.711060", "PMC8343100", "34367173"]}, {"Citation": "Rodriguez-Zuniga MJM, Garcia-Perdomo HA. Systematic review and metaanalysis of the association between psoriasis and metabolic syndrome. J Am Acad Dermatol (2017) 77(4):657\u201366 e8. doi: 10.1016/j.jaad.2017.04.1133", "ArticleIdList": ["10.1016/j.jaad.2017.04.1133", "28917453"]}, {"Citation": "Snekvik I, Nilsen TIL, Romundstad PR, Saunes M. Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway. Br J Dermatol (2019) 180(1):94\u20139. doi: 10.1111/bjd.16885", "ArticleIdList": ["10.1111/bjd.16885", "29904911"]}, {"Citation": "Grass DS, Felkner RH, Chiang MY, Wallace RE, Nevalainen TJ, Bennett CF, et al. . Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J Clin Invest. (1996) 97(10):2233\u201341. doi: 10.1172/JCI118664", "ArticleIdList": ["10.1172/JCI118664", "PMC507302", "8636402"]}, {"Citation": "Murakami M, Yamamoto K, Taketomi Y. Phospholipase A2 in skin biology: new insights from gene-manipulated mice and lipidomics. Inflammation Regen. (2018) 38:31. doi: 10.1186/s41232-018-0089-2", "ArticleIdList": ["10.1186/s41232-018-0089-2", "PMC6284315", "30546811"]}, {"Citation": "Yamamoto K, Miki Y, Sato M, Taketomi Y, Nishito Y, Taya C, et al. . The role of group IIF-secreted phospholipase A2 in epidermal homeostasis and hyperplasia. J Exp Med (2015) 212(11):1901\u201319. doi: 10.1084/jem.20141904", "ArticleIdList": ["10.1084/jem.20141904", "PMC4612087", "26438362"]}, {"Citation": "Shao S, Chen J, Swindell WR, Tsoi LC, Xing X, Ma F, et al. . Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris. JCI Insight (2021) 6(20):e151911. doi: 10.1172/jci.insight.151911", "ArticleIdList": ["10.1172/jci.insight.151911", "PMC8564909", "34491907"]}, {"Citation": "Cao C, Huang W, Zhang N, Wu F, Xu T, Pan X, et al. . Narciclasine induces autophagy-dependent apoptosis in triple-negative breast cancer cells by regulating the AMPK-ULK1 axis. Cell Prolif. (2018) 51(6):e12518. doi: 10.1111/cpr.12518", "ArticleIdList": ["10.1111/cpr.12518", "PMC6528917", "30152053"]}, {"Citation": "Lv C, Huang Y, Huang R, Wang Q, Zhang H, Jin J, et al. . Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells. Mol Ther Oncolytics. (2022) 24:340\u201354. doi: 10.1016/j.omto.2021.12.025", "ArticleIdList": ["10.1016/j.omto.2021.12.025", "PMC8783118", "35118192"]}, {"Citation": "Dumont P, Ingrassia L, Rouzeau S, Ribaucour F, Thomas S, Roland I, et al. . The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts. Neoplasia (2007) 9(9):766\u201376. doi: 10.1593/neo.07535", "ArticleIdList": ["10.1593/neo.07535", "PMC1993861", "17898872"]}, {"Citation": "Lefranc F, Sauvage S, Van Goietsenoven G, Megalizzi V, Lamoral-Theys D, Debeir O, et al. . Narciclasine, a plant growth modulator, activates Rho and stress fibers in glioblastoma cells. Mol Cancer Ther (2009) 8(7):1739\u201350. doi: 10.1158/1535-7163.MCT-08-0932", "ArticleIdList": ["10.1158/1535-7163.MCT-08-0932", "19531573"]}, {"Citation": "Van Goietsenoven G, Hutton J, Becker JP, Lallemand B, Robert F, Lefranc F, et al. . Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas. FASEB J (2010) 24(11):4575\u201384. doi: 10.1096/fj.10-162263", "ArticleIdList": ["10.1096/fj.10-162263", "PMC3229423", "20643906"]}, {"Citation": "Qiu Y, Fang B, Thuy NTT, Li A, Yoo HM, Zheng X, et al. . Narciclasine suppresses esophageal cancer cell proliferation and migration by inhibiting the FAK signaling pathway. Eur J Pharmacol (2022) 921:174669. doi: 10.1016/j.ejphar.2021.174669", "ArticleIdList": ["10.1016/j.ejphar.2021.174669", "35248554"]}, {"Citation": "Lubahn C, Schaller JA, Shewmacker E, Wood C, Bellinger DL, Byron D, et al. . Preclinical efficacy of sodium narcistatin to reduce inflammation and joint destruction in rats with adjuvant-induced arthritis. Rheumatol Int (2012) 32(12):3751\u201360. doi: 10.1007/s00296-011-2217-z", "ArticleIdList": ["10.1007/s00296-011-2217-z", "22159913"]}, {"Citation": "Mikami M, Kitahara M, Kitano M, Ariki Y, Mimaki Y, Sashida Y, et al. . Suppressive activity of lycoricidinol (narciclasine) against cytotoxicity of neutrophil-derived calprotectin, and its suppressive effect on rat adjuvant arthritis model. Biol Pharm Bull (1999) 22(7):674\u20138. doi: 10.1248/bpb.22.674", "ArticleIdList": ["10.1248/bpb.22.674", "10443460"]}, {"Citation": "Yui S, Mikami M, Mimaki Y, Sashida Y, Yamazaki M. [Inhibition effect of Amaryllidaceae alkaloids, lycorine and lycoricidinol on macrophage TNF-alpha production]. Yakugaku Zasshi. (2001) 121(2):167\u201371. doi: 10.1248/yakushi.121.167", "ArticleIdList": ["10.1248/yakushi.121.167", "11218731"]}, {"Citation": "Julien SG, Kim SY, Brunmeir R, Sinnakannu JR, Ge X, Li H, et al. . Narciclasine attenuates diet-induced obesity by promoting oxidative metabolism in skeletal muscle. PloS Biol (2017) 15(2):e1002597. doi: 10.1371/journal.pbio.1002597", "ArticleIdList": ["10.1371/journal.pbio.1002597", "PMC5331945", "28207742"]}, {"Citation": "Gao Y, Yao X, Zhai Y, Li L, Li H, Sun X, et al. . Single cell transcriptional zonation of human psoriasis skin identifies an alternative immunoregulatory axis conducted by skin resident cells. Cell Death Dis (2021) 12(5):450. doi: 10.1038/s41419-021-03724-6", "ArticleIdList": ["10.1038/s41419-021-03724-6", "PMC8102483", "33958582"]}, {"Citation": "Harden JL, Krueger JG, Bowcock AM. The immunogenetics of psoriasis: a comprehensive review. J Autoimmun (2015) 64:66\u201373. doi: 10.1016/j.jaut.2015.07.008", "ArticleIdList": ["10.1016/j.jaut.2015.07.008", "PMC4628849", "26215033"]}, {"Citation": "Sabat R, Philipp S, Hoflich C, Kreutzer S, Wallace E, Asadullah K, et al. . Immunopathogenesis of psoriasis. Exp Dermatol (2007) 16(10):779\u201398. doi: 10.1111/j.1600-0625.2007.00629.x", "ArticleIdList": ["10.1111/j.1600-0625.2007.00629.x", "17845210"]}, {"Citation": "Chen Y, Song S, Wang Y, Zhu J, Li X. Potential mechanism of oral baicalin treating psoriasis via suppressing Wnt signaling pathway and inhibiting Th17/IL-17 axis by activating PPARgamma. Phytother Res (2022) 36(10):3969\u201387. doi: 10.1002/ptr.7546", "ArticleIdList": ["10.1002/ptr.7546", "35778948"]}, {"Citation": "Spector AA, Yorek MA. Membrane lipid composition and cellular function. J Lipid Res (1985) 26(9):1015\u201335. doi: 10.1016/S0022-2275(20)34276-0", "ArticleIdList": ["10.1016/S0022-2275(20)34276-0", "3906008"]}, {"Citation": "Harayama T, Riezman H. Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Biol (2018) 19(5):281\u201396. doi: 10.1038/nrm.2017.138", "ArticleIdList": ["10.1038/nrm.2017.138", "29410529"]}, {"Citation": "Tyrrell VJ, Ali F, Boeglin WE, Andrews R, Burston J, Birchall JC, et al. . Lipidomic and transcriptional analysis of the linoleoyl-omega-hydroxyceramide biosynthetic pathway in human psoriatic lesions. J Lipid Res (2021) 62:100094. doi: 10.1016/j.jlr.2021.100094", "ArticleIdList": ["10.1016/j.jlr.2021.100094", "PMC8326207", "34171322"]}, {"Citation": "Zeng C, Wen B, Hou G, Lei L, Mei Z, Jia X, et al. . Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis. Gigascience (2017) 6(10):1\u201311. doi: 10.1093/gigascience/gix087", "ArticleIdList": ["10.1093/gigascience/gix087", "PMC5647792", "29046044"]}, {"Citation": "Lei L, Yan B, Liu P, Li J, Chen C, Zhu W, et al. . Lysophosphatidic acid mediates the pathogenesis of psoriasis by activating keratinocytes through LPAR5. Signal Transduct Target Ther (2021) 6(1):19. doi: 10.1038/s41392-020-00379-1", "ArticleIdList": ["10.1038/s41392-020-00379-1", "PMC7810744", "33452232"]}, {"Citation": "Liu L, Wang J, Li HJ, Zhang S, Jin MZ, Chen ST, et al. . Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms. Front Immunol (2021) 12:759276. doi: 10.3389/fimmu.2021.759276", "ArticleIdList": ["10.3389/fimmu.2021.759276", "PMC8724303", "34992595"]}, {"Citation": "Kumar L, EF M. Mfuzz: a software package for soft clustering of microarray data. Bioinformation (2007) 2(1):5\u20137. doi: 10.6026/97320630002005", "ArticleIdList": ["10.6026/97320630002005", "PMC2139991", "18084642"]}, {"Citation": "Dean JM, Lodhi IJ. Structural and functional roles of ether lipids. Protein Cell (2018) 9(2):196\u2013206. doi: 10.1007/s13238-017-0423-5", "ArticleIdList": ["10.1007/s13238-017-0423-5", "PMC5818364", "28523433"]}, {"Citation": "Baxter AA, Hulett MD, Poon IK. The phospholipid code: a key component of dying cell recognition, tumor progression and host-microbe interactions. Cell Death Differ (2015) 22(12):1893\u2013905. doi: 10.1038/cdd.2015.122", "ArticleIdList": ["10.1038/cdd.2015.122", "PMC4816099", "26450453"]}, {"Citation": "Fu Y, Zou T, Shen X, Nelson PJ, Li J, Wu C, et al. . Lipid metabolism in cancer progression and therapeutic strategies. MedComm (2020). (2021) 2(1):27\u201359. doi: 10.1002/mco2.27", "ArticleIdList": ["10.1002/mco2.27", "PMC8491217", "34766135"]}, {"Citation": "Dennis EA, Cao J, Hsu Y-H, Magrioti V, Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev (2011) 111(10):6130\u201385. doi: 10.1021/cr200085w", "ArticleIdList": ["10.1021/cr200085w", "PMC3196595", "21910409"]}, {"Citation": "Pruzanski W, Vadas P. Phospholipase A2 and inflammation. Ann Rheumatic Diseases. (1989) 48(11):962. doi: 10.1136/ard.48.11.962-b", "ArticleIdList": ["10.1136/ard.48.11.962-b", "PMC1003924", "2596887"]}, {"Citation": "Yamamoto K, Miki Y, Sato H, Nishito Y, Gelb MH, Taketomi Y, et al. . Expression and function of group IIE phospholipase A2 in mouse skin. J Biol Chem (2016) 291(30):15602\u201313. doi: 10.1074/jbc.M116.734657", "ArticleIdList": ["10.1074/jbc.M116.734657", "PMC4957045", "27226633"]}, {"Citation": "Cheung KL, Jarrett R, Subramaniam S, Salimi M, Gutowska-Owsiak D, Chen YL, et al. . Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a. J Exp Med (2016) 213(11):2399\u2013412. doi: 10.1084/jem.20160258", "ArticleIdList": ["10.1084/jem.20160258", "PMC5068234", "27670592"]}, {"Citation": "Omland S, Habicht A, Damsbo P, Wilms J, Johansen B, Gniadecki R. A randomized, double-blind, placebo-controlled, dose-escalation first-in-man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, AVX 001, in patients with mild to moderate plaque psoriasis. J Eur Acad Dermatol Venereology. (2017) 31(7):1161\u20137. doi: 10.1111/jdv.14128", "ArticleIdList": ["10.1111/jdv.14128", "28107559"]}, {"Citation": "McDermott MI, Wang Y, Wakelam MJO, Bankaitis VA. Mammalian phospholipase D: Function, and therapeutics. Prog Lipid Res (2020) 78:101018. doi: 10.1016/j.plipres.2019.101018", "ArticleIdList": ["10.1016/j.plipres.2019.101018", "PMC7233427", "31830503"]}, {"Citation": "Li H, Zuo J, Tang W. Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases. Front Pharmacol (2018) 9:1048. doi: 10.3389/fphar.2018.01048", "ArticleIdList": ["10.3389/fphar.2018.01048", "PMC6199465", "30386231"]}, {"Citation": "Rapalli VK, Waghule T, Gorantla S, Dubey SK, Saha RN, Singhvi G. Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems. Drug Discovery Today (2020) 25(12):2212\u201326. doi: 10.1016/j.drudis.2020.09.023", "ArticleIdList": ["10.1016/j.drudis.2020.09.023", "33011340"]}, {"Citation": "Pietilainen KH, Rog T, Seppanen-Laakso T, Virtue S, Gopalacharyulu P, Tang J, et al. . Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PloS Biol (2011) 9(6):e1000623. doi: 10.1371/journal.pbio.1000623", "ArticleIdList": ["10.1371/journal.pbio.1000623", "PMC3110175", "21666801"]}, {"Citation": "Cho YK, Yoon YC, Im H, Son Y, Kim M, Saha A, et al. . Adipocyte lysoplasmalogenase TMEM86A regulates plasmalogen homeostasis and protein kinase A-dependent energy metabolism. Nat Commun (2022) 13(1):4084. doi: 10.1038/s41467-022-31805-3", "ArticleIdList": ["10.1038/s41467-022-31805-3", "PMC9283435", "35835749"]}, {"Citation": "Di'Narzo AF, Houten SM, Kosoy R, Huang R, Vaz FM, Hou R, et al. . Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic Targets. Gastroenterology (2022) 162(3):828\u201343 e11. doi: 10.1053/j.gastro.2021.11.015", "ArticleIdList": ["10.1053/j.gastro.2021.11.015", "PMC9214725", "34780722"]}, {"Citation": "Jang JE, Park HS, Yoo HJ, Baek IJ, Yoon JE, Ko MS, et al. . Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis in mice. Hepatology (2017) 66(2):416\u201331. doi: 10.1002/hep.29039", "ArticleIdList": ["10.1002/hep.29039", "PMC5503808", "28073164"]}, {"Citation": "Van Iderstine SC, Byers DM, Ridgway ND, Cook HW. Phospholipase D hydrolysis of plasmalogen and diacyl ethanolamine phosphoglycerides by protein kinase C dependent and independent mechanisms. J Lipid Mediators Cell signalling. (1997) 15:175\u201392. doi: 10.1016/S0929-7855(96)00552-4", "ArticleIdList": ["10.1016/S0929-7855(96)00552-4", "9034963"]}, {"Citation": "Yang H-C, Farooqui AA, Horrocks LA. Plasmalogen-selective phospholipase A2 and its role in signal transduction. J Lipid Mediators Cell signalling (1996) 14(1-3):9\u201313. doi: 10.1016/0929-7855(96)01502-7", "ArticleIdList": ["10.1016/0929-7855(96)01502-7", "8906539"]}, {"Citation": "Ryborg A, Gron B, Kragballe K. Increased lysophosphatidylcholine content in lesional psoriatic skin. Br J Dermatol (1995) 133(3):398\u2013402. doi: 10.1111/j.1365-2133.1995.tb02667.x", "ArticleIdList": ["10.1111/j.1365-2133.1995.tb02667.x", "8546994"]}, {"Citation": "Ryborg A, Deleuran B, Sogaard H, Kragballe K. Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes. Acta dermato-venereologica. (2000) 80:242\u20136. doi: 10.1080/000155500750012090", "ArticleIdList": ["10.1080/000155500750012090", "11028854"]}, {"Citation": "Kragballe K, Desjarlais L, Voorhees JJ. Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes. Br J Dermatol (1985) 113(1):43\u201352. doi: 10.1111/j.1365-2133.1985.tb02043.x", "ArticleIdList": ["10.1111/j.1365-2133.1985.tb02043.x", "2990516"]}, {"Citation": "Thommesen L, Sjursen W, Gasvik K, Hanssen W, Brekke OL, Skattebol L, et al. . Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. J Immunol (1998) 161(7):3421\u201330. doi:\u00a010.4049/jimmunol.161.7.3421", "ArticleIdList": ["10.4049/jimmunol.161.7.3421", "9759860"]}, {"Citation": "Ashcroft FJ, Mahammad N, Midtun Flatekval H, Jullumstro Feuerherm A, Johansen B. cPLA(2)alpha Enzyme Inhibition Attenuates Inflammation and Keratinocyte Proliferation. Biomolecules (2020) 10(10):1402. doi:\u00a010.3390/biom10101402", "ArticleIdList": ["10.3390/biom10101402", "PMC7600040", "33023184"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "10"}, {"Year": "2022", "Month": "12", "Day": "12"}, {"Year": "2023", "Month": "1", "Day": "26", "Hour": "2", "Minute": "55"}, {"Year": "2023", "Month": "1", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["36700214", "PMC9869703", "10.3389/fimmu.2022.1094375"]}}], "PubmedBookArticle": []}